GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 783 filers reported holding GLAXOSMITHKLINE PLC in Q2 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $1,063,000 | +10.5% | 27,199 | +0.3% | 0.29% | +13.2% |
Q4 2017 | $962,000 | -17.3% | 27,124 | -5.3% | 0.26% | -19.2% |
Q3 2017 | $1,163,000 | +6.3% | 28,634 | +13.0% | 0.32% | +3.9% |
Q2 2017 | $1,094,000 | +9.6% | 25,349 | +7.1% | 0.31% | +8.1% |
Q1 2017 | $998,000 | +12.1% | 23,673 | +2.4% | 0.28% | +9.3% |
Q4 2016 | $890,000 | -20.1% | 23,126 | -10.5% | 0.26% | -23.6% |
Q3 2016 | $1,114,000 | -6.5% | 25,837 | -6.0% | 0.34% | -8.6% |
Q2 2016 | $1,191,000 | +14.6% | 27,479 | +7.2% | 0.37% | +11.4% |
Q1 2016 | $1,039,000 | +3.8% | 25,624 | +3.3% | 0.33% | +1.2% |
Q4 2015 | $1,001,000 | +109.9% | 24,803 | +100.0% | 0.33% | -39.2% |
Q3 2015 | $477,000 | -4.0% | 12,403 | +3.9% | 0.54% | +11.1% |
Q2 2015 | $497,000 | +8.3% | 11,935 | +20.0% | 0.49% | +7.7% |
Q1 2015 | $459,000 | +10.6% | 9,949 | +2.4% | 0.45% | +21.2% |
Q4 2014 | $415,000 | – | 9,712 | – | 0.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Black Creek Investment Management Inc. | 7,951,626 | $318,224,000 | 10.49% |
Healthcare Value Capital, LLC | 120,000 | $4,802,000 | 9.01% |
KAHN BROTHERS GROUP INC | 1,605,014 | $64,232,661,000 | 8.03% |
Eversept Partners, LP | 693,685 | $28,091,890 | 7.87% |
EQUITY INVESTMENT CORP | 2,673,764 | $107,004,000 | 3.74% |
Sio Capital Management, LLC | 379,500 | $15,188,000 | 3.66% |
Martin Capital Partners, LLC | 115,448 | $4,620,000 | 3.27% |
Circle Road Advisors LP | 53,028 | $2,122,000 | 3.10% |
Keystone Financial Planning, Inc. | 156,968 | $6,282,000 | 3.07% |
CAMG Solamere Management, LLC | 160,294 | $6,415,000 | 2.94% |